Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.
Neurava has raised $4.0M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Neurava's investors include Union Chimique Belge, Elevate Ventures, MassChallenge, MedTech Innovator, Life Science Angels.
Neurava is headquartered in Baltimore, United States.
Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.
Neurava is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurava — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/neurava. Accessed July 19, 2026.
VCBacked. (2026). Neurava — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neurava
{{cite web |title=Neurava — Funding & Investors |url=https://www.vcbacked.co/company/neurava |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated